About a fifth of the population in the United Kingdom is 60 years or older, 1 yet people in this
age group receive 59% of dispensed prescriptions and account for more than half of NHS …

The occurrence of several geriatric conditions may influence the efficacy and limit the use of
drugs prescribed to treat chronic conditions. Functional and cognitive impairment, geriatric …

A prescription for better prescribing | The BMJ Skip to main content Intended for healthcare
professionals Access provided by Google Indexer Subscribe My Account My email alerts BMA …

Atherosclerosis causes nearly 75% of cardiovascular-related deaths and is found in 80% to
90% of adults≥ 30 years old in the United States. Successful treatment minimizes lifetime …

Aim To compare the safety and efficacy of once-daily pitavastatin (1, 2, and 4 mg) and
pravastatin (10, 20, and 40 mg) in elderly patients (≥ 65 years of age) with primary …

Pharmacological treatment of complex older adults with comorbidities, multiple impairments
in function, cognition, social status and geriatric syndromes represents a challenge for …

Objective: Case reports have suggested that lipid-lowering drugs (LLDs), especially statins,
could induce or reveal chronic muscle diseases. We conducted a study to evaluate the …

Coronary heart disease (CHD) is the leading cause of death among elderly patients and>
80% of all coronary deaths occur in patients> 65 years. Cerebrovascular events are also …

Table 1. Causes of polypharmacy. lenging to determine why a patient is on a certain
medication and therefore whether it is safe to discontinue it. In the UK, most prescribing is …

When healthcare professionals have the choice between several drug treatments for their
patients, they often experience considerable decision uncertainty because many decisions …